세계의 전립선 건강 시장 보고서(2025년)

Prostate health encompasses the overall well-being and proper functioning of the prostate gland, a small organ in men responsible for producing seminal fluid. Maintaining prostate health is crucial for urinary function, reproductive health, and the prevention of conditions such as prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Factors affecting prostate health include age, genetics, diet, lifestyle, and regular medical screenings.

The primary disease indications related to prostate health include prostate cancer, benign prostatic hyperplasia, and prostatitis. Prostate cancer originates in the prostate gland and is characterized by the uncontrolled growth of prostate cells, potentially leading to tumor formation and metastasis. Treatment options include hormonal therapy, chemotherapy, surgical procedures, and other approaches. Various distribution channels for prostate health treatments include e-commerce stores, pharmacies, and other outlets.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The prostate health market research report is one of a series of new reports from The Business Research Company that provides prostate health market statistics, including prostate health industry global market size, regional shares, competitors with a prostate health market share, detailed prostate health market segments, market trends and opportunities, and any further data you may need to thrive in the prostate health industry. This prostate health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prostate health market size has grown strongly in recent years. It will grow from $34.07 billion in 2024 to $37.23 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to aging population, increased psa screening, rising awareness campaigns, advancements in hormone therapy, growing incidence rates.

The prostate health market size is expected to see strong growth in the next few years. It will grow to $52.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to growing adoption of precision medicine, increasing use of ai-driven diagnostics, expansion of targeted radiotherapies, rising demand for minimally invasive treatments, improved genetic profiling for risk assessment. Major trends in the forecast period include AI-powered risk assessment, liquid biopsy advancements, next-generation radiotheranostics, immunotherapy innovations, real-time biomarker monitoring.

The forecast of 9.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. preventive prostate care by inflating prices of digital rectal exam (DRE) gloves and urinary flow meters developed in Malaysia and Mexico, resulting in reduced screening compliance and higher primary care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of prostate cancer is expected to drive the growth of the prostate health market. Prostate cancer occurs when cells in the prostate gland grow uncontrollably, with adenocarcinomas being the most common form in men. The rise in prostate cancer cases is primarily attributed to an aging population, increased screening practices, and lifestyle factors such as obesity and physical inactivity. Maintaining prostate health is crucial for preventing, detecting, and managing prostate cancer. For example, in January 2023, the American Cancer Society (ACS), a US-based nonprofit organization, projected approximately 288,300 new prostate cancer diagnoses in the U.S. in 2023, with an estimated 34,700 fatalities. As a result, the growing prevalence of prostate cancer is fueling the expansion of the prostate health market.

Leading companies in the prostate health market are leveraging technological advancements such as AI-powered risk assessment to enhance diagnostic accuracy and reduce unnecessary biopsies. AI-powered risk assessment utilizes artificial intelligence algorithms to analyze data, predict potential risks, and support informed decision-making for improved patient outcomes. For instance, in September 2024, Nanostics Inc., a Canada-based clinical-stage biotechnology company, partnered with Protean BioDiagnostics, a US-based biotechnology company, to launch CDX Prostate, a diagnostic tool designed for men at risk of aggressive prostate cancer. This tool integrates biological data, clinical information, and AI-powered learning models to generate a risk score, offering a more precise assessment compared to traditional methods. CDX Prostate assists healthcare providers and patients in determining whether to proceed with a biopsy following a high prostate-specific antigen (PSA) test result or an abnormal digital rectal exam (DRE).

In June 2024, Lantheus Holdings Inc., a US-based radiopharmaceutical company, acquired worldwide rights to Life Molecular Imaging's RM2 for an undisclosed amount. This acquisition aims to strengthen Lantheus' presence in prostate cancer treatment while expanding its pipeline to include breast and other cancers. RM2 is a novel radiotheranostic pair, including 177Lu-DOTA-RM2 and 68Ga-DOTA-RM2, which target the gastrin-releasing peptide receptor (GRPR). Life Molecular Imaging, a Germany-based radiopharmaceutical company, specializes in developing innovative radiopharmaceuticals to enhance early detection and diagnosis of chronic and life-threatening conditions.

Major players in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., and Alessa Therapeutics.

North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prostate health report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prostate health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prostate health market includes revenues earned by entities providing services such as diagnostic screening, medical consultations, prostate cancer treatments, minimally invasive procedures for benign prostatic hyperplasia (BPH), telemedicine consultations, and wellness programs focused on prostate health. Only goods and services traded between entities or sold to end consumers are included. The prostate health market consists of sales of pharmaceuticals, medical devices, dietary supplements, and diagnostic kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prostate Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prostate health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prostate health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prostate health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
• 2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
• 3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels
• Subsegments:
• 1) By Prostate Cancer: Localized Prostate Cancer; Metastatic Prostate Cancer
• 2) By Benign Prostate Hyperplasia: Mild BPH; Moderate BPH; Severe BPH
• 3) By Prostatitis: Acute Bacterial Prostatitis; Chronic Bacterial Prostatitis; Chronic Prostatitis (Non-Bacterial)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Siemens Healthineers AG; Bayer AG; Sanofi SA; AstraZeneca PLC; Abbott Laboratories; Novartis AG; Takeda Pharmaceutical Co Ltd; Astellas Pharma Inc; Genentech Inc.; Teleflex Inc.; Elekta AB; Myriad Genetics Inc.; Freenome; Theragenics Corporation; CureVac BV; ArsenalBio; Roivant Sciences; Artera Inc.; Veru Inc.; HistoSonics Inc.; Immunic Inc.; Ezra; Francis Medical; CorTechs Labs; Lucida Medical; Serimmune Inc.; Alessa Therapeutics.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prostate Health Market Characteristics

3. Prostate Health Market Trends And Strategies

4. Prostate Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Prostate Health Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prostate Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prostate Health Market Growth Rate Analysis
• 5.4. Global Prostate Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prostate Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prostate Health Total Addressable Market (TAM)

6. Prostate Health Market Segmentation

• 6.1. Global Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prostate Cancer
• Benign Prostate Hyperplasia
• Prostatitis
• 6.2. Global Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Therapy
• Chemotherapy
• Surgical Treatments
• Other Treatments
• 6.3. Global Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• E-Commerce Stores
• Pharmacies
• Other Distribution Channels
• 6.4. Global Prostate Health Market, Sub-Segmentation Of Prostate Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Localized Prostate Cancer
• Metastatic Prostate Cancer
• 6.5. Global Prostate Health Market, Sub-Segmentation Of Benign Prostate Hyperplasia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild BPH
• Moderate BPH
• Severe BPH
• 6.6. Global Prostate Health Market, Sub-Segmentation Of Prostatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Bacterial Prostatitis
• Chronic Bacterial Prostatitis
• Chronic Prostatitis (Non-Bacterial)

7. Prostate Health Market Regional And Country Analysis

• 7.1. Global Prostate Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prostate Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prostate Health Market

• 8.1. Asia-Pacific Prostate Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prostate Health Market

• 9.1. China Prostate Health Market Overview
• 9.2. China Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prostate Health Market

• 10.1. India Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prostate Health Market

• 11.1. Japan Prostate Health Market Overview
• 11.2. Japan Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prostate Health Market

• 12.1. Australia Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prostate Health Market

• 13.1. Indonesia Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prostate Health Market

• 14.1. South Korea Prostate Health Market Overview
• 14.2. South Korea Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prostate Health Market

• 15.1. Western Europe Prostate Health Market Overview
• 15.2. Western Europe Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prostate Health Market

• 16.1. UK Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prostate Health Market

• 17.1. Germany Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prostate Health Market

• 18.1. France Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prostate Health Market

• 19.1. Italy Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prostate Health Market

• 20.1. Spain Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prostate Health Market

• 21.1. Eastern Europe Prostate Health Market Overview
• 21.2. Eastern Europe Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prostate Health Market

• 22.1. Russia Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prostate Health Market

• 23.1. North America Prostate Health Market Overview
• 23.2. North America Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prostate Health Market

• 24.1. USA Prostate Health Market Overview
• 24.2. USA Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prostate Health Market

• 25.1. Canada Prostate Health Market Overview
• 25.2. Canada Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prostate Health Market

• 26.1. South America Prostate Health Market Overview
• 26.2. South America Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prostate Health Market

• 27.1. Brazil Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prostate Health Market

• 28.1. Middle East Prostate Health Market Overview
• 28.2. Middle East Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prostate Health Market

• 29.1. Africa Prostate Health Market Overview
• 29.2. Africa Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prostate Health Market Competitive Landscape And Company Profiles

• 30.1. Prostate Health Market Competitive Landscape
• 30.2. Prostate Health Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Prostate Health Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC
• 31.2. Abbott Laboratories
• 31.3. Novartis AG
• 31.4. Takeda Pharmaceutical Co Ltd
• 31.5. Astellas Pharma Inc
• 31.6. Genentech Inc.
• 31.7. Teleflex Inc.
• 31.8. Elekta AB
• 31.9. Myriad Genetics Inc.
• 31.10. Freenome
• 31.11. Theragenics Corporation
• 31.12. CureVac BV
• 31.13. ArsenalBio
• 31.14. Roivant Sciences
• 31.15. Artera Inc.

32. Global Prostate Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prostate Health Market

34. Recent Developments In The Prostate Health Market

35. Prostate Health Market High Potential Countries, Segments and Strategies

• 35.1 Prostate Health Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prostate Health Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prostate Health Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer